Literature DB >> 12162699

Highly immunostimulatory CpG-free oligodeoxynucleotides for activation of human leukocytes.

Jorg Vollmer1, Andrea Janosch, Meike Laucht, Zuhair K Ballas, Christian Schetter, Arthur M Krieg.   

Abstract

Synthetic oligodeoxynucleotides (ODNs) bearing CpG dinucleotides can mimic the immunostimulatory effects of bacterial DNA in vertebrates. Besides the known CpG motifs, no other sequence motif has been shown to have independent immunostimulatory effects. Several past investigators have demonstrated that the nucleotide content or the phosphorothioate (PS) backbone may have effects independently of the sequence. However, the effect of both nucleotide content and PS backbone to stimulate human leukocytes is not well understood. We investigated the immunostimulatory activity of 34 PS-ODNs with different nucleotide contents, lengths, and methylation status on human leukocytes. The thymidine content showed strong CpG-independent contribution to immunostimulation. In contrast, ODNs rich in other nucleotides (guanosine, cytosine, or adenosine) induced no or much lower levels of immunostimulation. The observed effects were highly dependent on the PS backbone chemistry. In addition to the base content and the backbone chemistry, the length of the PS-ODN was directly related to the magnitude of its stimulatory effects, especially on B cells. In addition, methylation of CpG dinucleotides did not always cause an abrogation of the immunostimulation. Immunostimulatory effects could be observed with methylated CpG ODNs, specifically as the ODN length was increased from 18 to 24 or more nucleotides (nt). In contrast, PS-ODNs with inverted CpG dinucleotides showed some but only weak immunostimulation. Our results demonstrate that non-CpG ODNs rich in thymidine or ODNs with methylated CpG motifs have length-dependent immunostimulatory effects. Such ODNs can induce effects similar to those seen with CpG ODNs but are much less efficient in stimulating human immune cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12162699     DOI: 10.1089/108729002760220761

Source DB:  PubMed          Journal:  Antisense Nucleic Acid Drug Dev        ISSN: 1087-2906


  16 in total

1.  Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.

Authors:  Jörg Vollmer; Risini D Weeratna; Marion Jurk; Ulrike Samulowitz; Michael J McCluskie; Paul Payette; Heather L Davis; Christian Schetter; Arthur M Krieg
Journal:  Immunology       Date:  2004-10       Impact factor: 7.397

2.  CpG and non-CpG oligodeoxynucleotides directly costimulate mouse and human CD4+ T cells through a TLR9- and MyD88-independent mechanism.

Authors:  Angela Landrigan; Michael T Wong; Paul J Utz
Journal:  J Immunol       Date:  2011-08-15       Impact factor: 5.422

3.  Human complement receptor 2 (CR2/CD21) as a receptor for DNA: implications for its roles in the immune response and the pathogenesis of systemic lupus erythematosus (SLE).

Authors:  Rengasamy Asokan; Nirmal K Banda; Gerda Szakonyi; Xiaojiang S Chen; V Michael Holers
Journal:  Mol Immunol       Date:  2012-08-10       Impact factor: 4.407

Review 4.  Modulation of NK cell activity by CpG oligodeoxynucleotides.

Authors:  Zuhair K Ballas
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

5.  In vivo efficacy of a phosphodiester TLR-9 aptamer and its beneficial effect in a pulmonary anthrax infection model.

Authors:  Christina C N Wu; Mojgan Sabet; Tomoko Hayashi; Rommel Tawatao; Joshua Fierer; Dennis A Carson; Donald G Guiney; Maripat Corr
Journal:  Cell Immunol       Date:  2008-05-20       Impact factor: 4.868

6.  Autoreactive B cells discriminate CpG-rich and CpG-poor DNA and this response is modulated by IFN-alpha.

Authors:  Melissa B Uccellini; Liliana Busconi; Nathaniel M Green; Patricia Busto; Sean R Christensen; Mark J Shlomchik; Ann Marshak-Rothstein; Gregory A Viglianti
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

7.  Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection.

Authors:  Linda J Berry; Danica K Hickey; Kathryn A Skelding; Shisan Bao; Amanda M Rendina; Philip M Hansbro; Christine M Gockel; Kenneth W Beagley
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

8.  Circulating bacterial-derived DNA fragments and markers of inflammation in chronic hemodialysis patients.

Authors:  Maurizio Bossola; Maurizio Sanguinetti; Donata Scribano; Cecilia Zuppi; Stefania Giungi; Giovanna Luciani; Riccardo Torelli; Brunella Posteraro; Giovanni Fadda; Luigi Tazza
Journal:  Clin J Am Soc Nephrol       Date:  2008-12-31       Impact factor: 8.237

9.  Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals.

Authors:  Jeffrey A Martinson; Allan R Tenorio; Carlos J Montoya; Lena Al-Harthi; Carolyne N Gichinga; Arthur M Krieg; Linda L Baum; Alan L Landay
Journal:  Immunology       Date:  2007-04       Impact factor: 7.397

10.  Oligonucleotides suppress PKB/Akt and act as superinductors of apoptosis in human keratinocytes.

Authors:  Stefan Kippenberger; Jutta Müller; Maike Schultz; Annette Dorn; Andreas Bock; Hüseyin Aygün; Diamant Thaçi; Matthias Hofmann; Roland Kaufmann; August Bernd
Journal:  Nucleic Acids Res       Date:  2009-04-22       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.